Gary Mintchell

NOVEMBER 15, 2024

In this insight, we will discuss two new growth areas identified from our research and conversations with manufacturers: smart conveyance technology and robots with machine-integrated control.” By 2029, sales of linear systems are expected to exceed $1.1 billion, nearly five times the market size in 2020.

Robotics 130

Robotics Robotics Automation Pharmaceutical 130

Automation Mag

OCTOBER 17, 2024

In 2023, the market grew by 23 percent, largely driven by the battery manufacturing industry. percent between 2024 and 2029, with $1.1 billion in sales projected for 2029. percent forecast from 2023 to 2029. By 2029, the market size is projected to be worth more than $80 million, notes the firm.

Electronics 59

Electronics Pharmaceutical Smart manufacturing Automation 59

Robotics Business Review

JUNE 20, 2024

Source: Zebra Technologies Only 1 in 6 manufacturers has a clear understanding of its own processes, according to a new study from Zebra Technologies Corp. The report also found that 61% of manufacturers expect artificial intelligence to drive growth by 2029, up from 41% in 2024. Zebra commissioned Azure Knowledge Corp.

Manufacturing 107

Manufacturing Supply Chain Robotics Robotics 107

Robotics Business Review

NOVEMBER 3, 2024

Interact Analysis here discusses two new growth areas it has identified from its research and conversations with manufacturers: smart conveyance technology and robots with machine-integrated control. By 2029, sales of linear systems could exceed $1.1 billion, nearly five times the market size in 2020, according to Interact Analysis.

Robotics 59

Robotics Robotics Automation Pharmaceutical 59

AU Manufacturing

FEBRUARY 14, 2023

million for a further seven years, or until 2029, to continue its support for life science investment fund Brandon BioCatalyst , to which it has given $2.52 million to Brandon BioCatalyst for the period 2008-2029 with the hope of nurturing ground-breaking WA biomedical discoveries,” said Medical Research Minister Stephen Dawson.

Pharmaceutical 52

Pharmaceutical Manufacturing 52

Frost & Sullivan Manufacturing

JUNE 24, 2024

The key imperatives for oncology industry stakeholders includes: Collaboration between pharmaceutical companies, the government, academics, and diagnostics providers are crucial for personalized medicine adoption and development.

Artificial Intelligence 52

Artificial Intelligence Pharmaceutical 52

Frost & Sullivan Manufacturing

APRIL 3, 2025

Highlighting significant advancements in encapsulation technologies, Benoit Butruille, Advisory Director, added: Advanced encapsulation techniques are revolutionising pharmaceuticals, food, and personal care products, improving stability, bioavailability, and controlled release.

Pharmaceutical 90

Pharmaceutical Supply Chain Electronics Automation 90